Brainstorm Cell Therapeutics | BCLI - Capital Ordinário

Preço das Ações
0.89
Mudança Diária
-0.03 -3.24%
Mensal
-0.77%
Anual
15.07%
Q2 Previsão
0.90




Capital Ordinário Alterar Data
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Biogen USD 146.7M 200K 2025-09
Brainstorm Cell Therapeutics USD 11.04M 2K 2025-12
Cipla INR 807.77M 807.43M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
CSL USD 482.13M 93.87M 2025-12
Cytokinetics USD 122.26M 145K 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
Grifols EUR 680.58M 846.11K 2025-12
Halozyme Therapeutics USD 117.78M 259K 2025-12
Mesoblast USD 1.29B 8.58M 2025-12